{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:11:42Z","timestamp":1792401102684,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005562","name":"North Carolina Biotechnology Center","doi-asserted-by":"publisher","award":["9903-IDG-1002"],"award-info":[{"award-number":["9903-IDG-1002"]}],"id":[{"id":"10.13039\/100005562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005562","name":"North Carolina Biotechnology Center","doi-asserted-by":"publisher","award":["2007-IDG-1021"],"award-info":[{"award-number":["2007-IDG-1021"]}],"id":[{"id":"10.13039\/100005562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-64163"],"award-info":[{"award-number":["HL-64163"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-49373"],"award-info":[{"award-number":["HL-49373"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 S10 RR17846"],"award-info":[{"award-number":["1 S10 RR17846"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA12197"],"award-info":[{"award-number":["5P30CA12197"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.bbalip.2011.08.019","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T06:35:29Z","timestamp":1316154929000},"page":"502-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice"],"prefix":"10.1016","volume":"1821","author":[{"given":"Mary G.","family":"Sorci-Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Zabalawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish S.","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela F.","family":"Asztalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaila","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2011.08.019_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-2275(20)33893-1","article-title":"ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice","volume":"39","author":"Voyiaziakis","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.08.019_bb0020","doi-asserted-by":"crossref","first-page":"62i","DOI":"10.1016\/S0002-9149(02)02635-8","article-title":"High-density lipoproteins and atherosclerosis","volume":"90","author":"Rader","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0025","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1172\/JCI8119","article-title":"The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway","volume":"104","author":"Lawn","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0030","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1194\/jlr.M300078-JLR200","article-title":"ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions","volume":"44","author":"Vaughan","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e328338472d","article-title":"High-density lipoprotein heterogeneity and function in reverse cholesterol transport","volume":"21","author":"Rothblat","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0045","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1074\/jbc.275.16.12156","article-title":"Single repeat deletion in apoA-I blocks cholesterol esterification and results in rapid catabolism of D6 and wild-type apoA-I in transgenic mice","volume":"275","author":"Sorci-Thomas","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0050","doi-asserted-by":"crossref","first-page":"21403","DOI":"10.1016\/S0021-9258(19)36938-8","article-title":"Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships","volume":"268","author":"Sorci-Thomas","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cmet.2008.03.001","article-title":"HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis","volume":"7","author":"Tall","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/ATVBAHA.108.179283","article-title":"Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0065","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.RES.0000250171.54048.5c","article-title":"ATP-Binding cassette cholesterol transporters and cardiovascular disease","volume":"99","author":"Oram","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0070","doi-asserted-by":"crossref","first-page":"32336","DOI":"10.1074\/jbc.M109.047472","article-title":"The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor","volume":"284","author":"Tang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1050-1738(01)00163-3","article-title":"The effects of altered apolipoprotein A-I structure on plasma HDL concentration","volume":"12","author":"Sorci-Thomas","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/hmg\/8.2.331","article-title":"Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey","volume":"8","author":"Yamakawa-Kobayashi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0085","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1172\/JCI109957","article-title":"A-IMilano Apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.","volume":"66","author":"Weisgraber","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9150(97)00195-0","article-title":"Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano)","volume":"136","author":"Chiesa","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2011.08.019_bb0095","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/S0022-2275(20)34945-2","article-title":"High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice","volume":"38","author":"Bielicki","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0100","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.ATV.17.9.1637","article-title":"Evidence that apolipoprotein A-IMilano has reduced capacity, compared with wild-type apolipoprotein A-I, to recruit membrane cholesterol","volume":"17","author":"Bielicki","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0105","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/ATVBAHA.109.191379","article-title":"Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano","volume":"29","author":"Alexander","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0110","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/ATVBAHA.107.148403","article-title":"Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux","volume":"27","author":"Weibel","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0115","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2011.08.019_bb0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2005.03.008","article-title":"Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model","volume":"183","author":"Parolini","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2011.08.019_bb0125","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1074\/jbc.M207335200","article-title":"Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion","volume":"278","author":"Parolini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.ATV.17.1.83","article-title":"Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene","volume":"17","author":"Miettinen","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0135","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1161\/01.ATV.17.11.3021","article-title":"Apolipoprotein A-IFIN (Leu159\u2013>Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts","volume":"17","author":"Miettinen","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0140","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1021\/bi7003203","article-title":"LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN","volume":"46","author":"Koukos","year":"2007","journal-title":"Biochemistry"},{"issue":"Suppl 1","key":"10.1016\/j.bbalip.2011.08.019_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/07853890701687219","article-title":"Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models","volume":"40","author":"Zannis","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0150","doi-asserted-by":"crossref","first-page":"21292","DOI":"10.1074\/jbc.M100463200","article-title":"Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia","volume":"276","author":"McManus","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0155","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9440(10)63480-3","article-title":"Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol","volume":"163","author":"Zabalawi","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1194\/jlr.M600370-JLR200","article-title":"Inflammation and skin cholesterol in LDLr\u2212\/\u2212, apoA-I\u2212\/\u2212 mice: link between cholesterol homeostasis and self-tolerance?","volume":"48","author":"Zabalawi","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0165","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.RES.0000185320.82962.F7","article-title":"Increased Atherosclerosis in Mice Lacking Apolipoprotein A-I Attributable to Both Impaired Reverse Cholesterol Transport and Increased Inflammation","volume":"97","author":"Moore","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0170","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/01.ATV.0000092328.66882.F5","article-title":"Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor","volume":"23","author":"Moore","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0175","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/ATVBAHA.108.183442","article-title":"Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity","volume":"29","author":"Wilhelm","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0180","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1016\/S0021-9258(18)53085-4","article-title":"A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice","volume":"268","author":"Simonet","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0185","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1194\/jlr.M300498-JLR200","article-title":"Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions","volume":"45","author":"Bhat","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0190","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.ATV.18.11.1818","article-title":"Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB100 - overexpression transgenic mice","volume":"18","author":"Rudel","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"19","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1194\/jlr.D600031-JLR200","article-title":"Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin","volume":"48","author":"Owen","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0205","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-2275(20)40766-7","article-title":"HepG2 cell LDL receptor activity and the accumulation of apolipoprotein B and E in response to docosahexaenoic acid and cholesterol","volume":"33","author":"Sorci-Thomas","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0210","doi-asserted-by":"crossref","first-page":"33015","DOI":"10.1074\/jbc.M505081200","article-title":"Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry","volume":"280","author":"Bhat","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0215","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00042737-200012080-00012","article-title":"An improved ex vivo method of primary porcine hepatocyte isolation for use in bioartificial liver systems","volume":"12","author":"Nelson","year":"2000","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0220","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.1016\/S0021-9258(17)37109-0","article-title":"Apolipoprotein B48-Membrane Interactions. Absence of transmembrane localization to nonhepatic cells","volume":"269","author":"Shelness","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0225","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/ATVBAHA.107.142455","article-title":"Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1","volume":"27","author":"Mulya","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0230","doi-asserted-by":"crossref","first-page":"41835","DOI":"10.1074\/jbc.M204923200","article-title":"Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux","volume":"277","author":"See","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0235","doi-asserted-by":"crossref","first-page":"36158","DOI":"10.1074\/jbc.M110.134130","article-title":"Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr\u2212\/\u2212, ApoA-I\u2212\/\u2212 mice","volume":"285","author":"Wilhelm","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0240","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1021\/bi1003734","article-title":"Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles","volume":"49","author":"Bhat","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2011.08.019_bb0245","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-2275(20)37608-2","article-title":"High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression","volume":"37","author":"Sorci-Thomas","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0250","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0255","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/S0022-2275(20)34897-5","article-title":"Sterol synthesis is up-regulated in cholesterol-loaded pigeon macrophages during induction of cholesterol efflux","volume":"40","author":"Nordskog","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02668129","article-title":"Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots","volume":"1","author":"Rouser","year":"1966","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2011.08.019_bb0265","doi-asserted-by":"crossref","first-page":"12E","DOI":"10.1016\/S0002-9149(02)03383-0","article-title":"High-density lipoprotein subpopulations in pathologic conditions","volume":"91","author":"Asztalos","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbalip.2011.08.019_bb0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:16:14Z","timestamp":1778613374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198111001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1388198111001715"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.08.019","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}